A prominent Member of the European Parliament has urged the European biotech industry to defend its processes ... food conference this week, Fine Gael MEP Avril Doyle alluded to the ...

The Global Biotech Industry Outlook for 2025 aims to provide ... aims to leverage both real-world data (RWD) and biological modeling to support efficient hypothesis generation and rapid validation ...

all of the precompetitive initiatives between pharma/biotech companies and academia remain distinctly early stage, if not exploratory. Precisely how the industry will shape these new models of ...

Excessively long approval timelines and outdated regulations designed for chemicals are harming Europe’s competitive edge in the biosolutions industry, according to MEP Morten Løkkegaard (Renew).